NovoCure Ltd — Director's Dealing 2019

May 31, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-05-29

Reporting Person: PHILLIPS CHARLES G III (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-29	Ordinary Shares	M	50000	$6.72	Acquired	59504	Direct
2019-05-29	Ordinary Shares	S	47080	$52.088	Disposed	12424	Direct
2019-05-29	Ordinary Shares	S	2920	$52.844	Disposed	9504	Direct
2019-05-29	Ordinary Shares	M	21500	$11.39	Acquired	31004	Direct
2019-05-29	Ordinary Shares	S	16326	$52.086	Disposed	14678	Direct
2019-05-29	Ordinary Shares	S	5174	$52.961	Disposed	9504	Direct
2019-05-29	Ordinary Shares	M	23600	$12.30	Acquired	33104	Direct
2019-05-29	Ordinary Shares	S	22200	$52.084	Disposed	10904	Direct
2019-05-29	Ordinary Shares	S	1400	$52.821	Disposed	9504	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-29	Options to Buy Ordinary Shares	$6.72	M	50000	Disposed	2022-09-28	Ordinary Shares (50000)	Direct
2019-05-29	Options to Buy Ordinary Shares	$11.39	M	21500	Disposed	2026-05-04	Ordinary Shares (21500)	Direct
2019-05-29	Options to Buy Ordinary Shares	$12.30	M	23600	Disposed	2027-05-09	Ordinary Shares (23600)	Direct

Footnotes

F1: On May 29, 2019, Mr. Phillips sold 47,080 shares in multiple trades at prices ranging from $51.62 to $52.61. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: On May 29, 2019, Mr. Phillips sold 2,920 shares in multiple trades at prices ranging from $52.64 to $53.06. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On May 29, 2019, Mr. Phillips sold 16,326 shares in multiple trades at prices ranging from $51.57 to $52.56. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: On May 29, 2019, Mr. Phillips sold 5,174 shares in multiple trades at prices ranging from $52.58 to $53.30. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F5: On May 29, 2019, Mr. Phillips sold 22,200 shares in multiple trades at prices ranging from $51.63 to $52.61. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F6: On May 29, 2019, Mr. Phillips sold 1,400 shares in multiple trades at prices ranging from $52.63 to $52.96. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F7: Options to buy 50,000 ordinary shares are vested and currently exercisable as of the date hereof.